Device Core Lab

Bcm For Cobas 8100

Payments companies reported to CMS as associated with Bcm For Cobas 8100. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$57Kassociated payments (2023-2025)
11clinicians with associated payments
1company reporting

By year

2023 $57K
2024 $124
2025 $33.85

Payments reported as associated with Bcm For Cobas 8100, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $26K
Clinical Pathology/Laboratory Medicine $14K
Molecular Genetic Pathology (Pathology) $10K
Pediatric Nephrology $6,753
Clinical Pathology $33.85

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Bcm For Cobas 8100

These are the largest totals companies reported as associated with Bcm For Cobas 8100. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Lucia Wolgast Bronx, NY Anatomic Pathology & Clinical Pathology $19,513.95
He Yang Valencia, CA Clinical Pathology/Laboratory Medicine $12,035.44
Doctor Goldstein Bronx, NY Molecular Genetic Pathology (Pathology) $10,275.01
Amy Fox Bronx, NY Pediatric Nephrology $6,752.89
Myra Wilkerson Danville, PA Anatomic Pathology & Clinical Pathology $5,117.47
Michael Prystowsky Bronx, NY Clinical Pathology/Laboratory Medicine $2,210.64
Guillermo Martinez Torres Milwaukee, WI Anatomic Pathology & Clinical Pathology $745.22
Robert Carlson Scarborough, ME Anatomic Pathology & Clinical Pathology $572.78
Edmunds Reineks Cleveland, OH Clinical Pathology/Laboratory Medicine $124.28
Jason Loos Lubbock, TX Anatomic Pathology & Clinical Pathology $64.92

Prescribed Bcm For Cobas 8100?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.